IRIS
PLATANIA, CHIARA BIANCA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.713
AS - Asia 1.336
EU - Europa 1.149
AF - Africa 293
SA - Sud America 241
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 5.739
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.635
SG - Singapore 636
IT - Italia 551
CN - Cina 444
BR - Brasile 211
IE - Irlanda 201
CI - Costa d'Avorio 182
UA - Ucraina 87
DE - Germania 74
SN - Senegal 70
VN - Vietnam 70
KR - Corea 64
CA - Canada 50
GB - Regno Unito 44
RU - Federazione Russa 42
SE - Svezia 32
IN - India 31
FI - Finlandia 25
PL - Polonia 23
JP - Giappone 21
MX - Messico 19
AR - Argentina 15
HK - Hong Kong 12
NL - Olanda 12
ZA - Sudafrica 12
FR - Francia 11
BD - Bangladesh 10
ES - Italia 10
BE - Belgio 8
NG - Nigeria 8
TR - Turchia 8
BJ - Benin 7
CH - Svizzera 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
EC - Ecuador 5
IQ - Iraq 5
KE - Kenya 5
LT - Lituania 5
CZ - Repubblica Ceca 4
EU - Europa 4
ID - Indonesia 4
MA - Marocco 4
TN - Tunisia 4
UZ - Uzbekistan 4
AU - Australia 3
CO - Colombia 3
GR - Grecia 3
NP - Nepal 3
PK - Pakistan 3
PY - Paraguay 3
AL - Albania 2
AZ - Azerbaigian 2
GT - Guatemala 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
LK - Sri Lanka 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
YE - Yemen 1
Totale 5.739
Salva come PNG Salva come JPEG
Città #
Santa Clara 438
Dallas 421
Singapore 339
Chandler 321
Dublin 201
Abidjan 182
Catania 177
Chicago 161
Hefei 120
Ashburn 114
Jacksonville 94
Houston 88
Boardman 82
Beijing 72
Dakar 70
Seoul 61
Los Angeles 54
Cambridge 48
Lawrence 47
Andover 43
Civitanova Marche 35
New York 28
Ho Chi Minh City 27
Toronto 27
Wilmington 27
Des Moines 24
Nanjing 23
Rome 22
São Paulo 22
Bremen 21
Buffalo 19
Seattle 19
The Dalles 18
Hanoi 17
Tokyo 17
Warsaw 17
Aci Catena 16
Columbus 16
Falls Church 16
Messina 16
Council Bluffs 15
Palermo 15
Milan 13
Rio de Janeiro 13
Lappeenranta 12
Munich 12
Orem 12
Stockholm 12
Brooklyn 11
Phoenix 11
Redwood City 11
Boydton 10
Changsha 10
Dong Ket 10
Hebei 10
Ottawa 10
Saint Petersburg 10
Shenyang 10
Belo Horizonte 9
Hong Kong 9
Manchester 9
Mumbai 9
Naples 9
San Mateo 9
Abuja 8
Grafing 8
Redmond 8
Redondo Beach 8
Cotonou 7
Jiaxing 7
Johannesburg 7
Mexico City 7
Montreal 7
Nanchang 7
San Gregorio di Catania 7
Atlanta 6
Chennai 6
Dearborn 6
Guangzhou 6
Pozzallo 6
Rosolini 6
Shanghai 6
Brasília 5
Bronte 5
Brussels 5
Cagliari 5
Curitiba 5
Denver 5
Hyderabad 5
London 5
Manaus 5
Moscow 5
Nairobi 5
San Francisco 5
Turku 5
Washington 5
Ankara 4
Baranzate 4
Boston 4
Busto Garolfo 4
Totale 4.030
Salva come PNG Salva come JPEG
Nome #
Current drug treatments targeting dopamine D3 receptor 202
Antioxidant and osmoprotecting activity of taurine in dry eye models 157
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 129
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 129
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 128
Caffeine Protects Against Retinal Inflammation 125
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 121
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 120
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 118
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 115
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 111
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 108
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy 107
Controversies in Glaucoma: Current Medical Treatment and Drug Development 106
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 103
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 101
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 101
P2X7 receptor antagonism: implications in diabetic retinopathy 100
Drug delivery of synthetic antisense “Bioconjugates” for anticancer therapy DNA. 100
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice 99
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 98
Novel therapeutics in glaucoma management 97
Retinal protection and distribution of curcumin in vitro and in vivo 96
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 92
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 92
Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study 91
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 91
Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via p2x7 receptor 91
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 89
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 89
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 89
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 89
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 89
New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery 87
Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells 87
Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy 86
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 86
Drug Delivery of Synthetic Antisense-DNA “bioconjugates” for Anticancer Therapy 86
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 85
DRUG DELIVERY OF SYNTHETIC ANTISENSE-DNA "BIOCONJUGATES" FOR ANTICANCER THERAPY 83
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 83
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 83
Do extracellular RNAs provide insight into uveal melanoma biology? 82
Ocular pharmacological profile of hydrocortisone in dry eye disease 81
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets? 75
Integrating network pharmacology: The next-generation approach in ocular drug discovery 73
Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration 73
Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR) 72
In-Silico Characterization of von Willebrand Factor Bound to FVIII 71
Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease 70
Ocular allergy 70
Novel heme oxygenase-1 (Ho-1) inducers based on dimethyl fumarate structure 70
MicroRNA target prediction in glaucoma 68
Molecular basis of alcohol intake: role of D3 dopaminergic receptor 68
Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose 67
Characterization of protein-protein interfaces through a protein contact network approach 63
Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors 62
The P2X7 receptor as a new pharmacological target for retinal diseases 58
Implications of dopamine D3 receptor for glaucoma: in-silico and in-vivo studies 56
Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study 55
Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach. 51
Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs 49
Erratum: Homology modeling of dopamine D2 and D3 receptors: Molecular dynamics refinement and docking evaluation (PLoS ONE (2013) 8:1 DOI: 10.1371/annotation/bd61cc74-2a2c-4433-a78d-84fa2310e919) 48
The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach 48
Ocular Allergies 46
α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells 42
Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease 13
Totale 5.870
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.180
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021186 0 0 0 0 53 13 34 5 19 15 27 20
2021/2022385 31 45 10 6 50 18 64 21 32 6 19 83
2022/2023927 61 66 17 109 121 120 16 170 173 16 31 27
2023/2024403 32 43 18 21 31 115 7 30 1 3 57 45
2024/20251.769 42 254 75 128 373 242 100 56 129 106 152 112
2025/20261.692 243 184 604 251 410 0 0 0 0 0 0 0
Totale 5.870